Bruker (NASDAQ: BRKR) reported Q1 EPS of $0.31, $0.08 better than the analyst estimate of $0.23. Revenue for the quarter came in at $823.4 million versus the consensus estimate of $796.15 million.

GUIDANCE:

Bruker sees FY2026 EPS of $2.10-$2.15, versus the consensus of $2.12. Bruker sees FY2026 revenue of $3.57-3.6 billion, versus the consensus of $3.58 billion.

For earnings history and earnings-related data on Bruker (BRKR) click here.